<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:circular="https://rhnvrm.github.io/stock-market-circulars/ns"><channel><title>JUSTDIAL - Stock Market Circulars</title><link>https://rhnvrm.github.io/stock-market-circulars/tags/justdial/</link><description>Regulatory circulars from NSE, BSE, and SEBI with AI-powered summaries</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Tue, 19 May 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://rhnvrm.github.io/stock-market-circulars/tags/justdial/feed.xml" rel="self" type="application/rss+xml"/><item><title>NSE Listing of Further Issues of Securities - 11 Companies (ESOP &amp; Preferential Allotments)</title><link>https://rhnvrm.github.io/stock-market-circulars/circulars/nse/2026/nse-2026-05-19-20e659b982e21c6c-listing-of-further-issues-of-securities/</link><pubDate>Tue, 19 May 2026 00:00:00 +0530</pubDate><guid>https://rhnvrm.github.io/stock-market-circulars/circulars/nse/2026/nse-2026-05-19-20e659b982e21c6c-listing-of-further-issues-of-securities/</guid><description>NSE notifies listing of additional equity shares for 11 companies including Ather Energy, Bajaj Healthcare, CREDITACCESS GRAMEEN, Eris Lifesciences, GHCL, Just Dial, Larsen &amp; Toubro, FSN E-Commerce, Piccadily Agro, Virinchi, and Vishal Mega Mart, effective May 20, 2026.</description><circular:source>nse</circular:source><circular:category>listing</circular:category><circular:impact>low</circular:impact><circular:severity>low</circular:severity><circular:importance>low</circular:importance><circular:id>20e659b982e21c6c</circular:id><circular:pdfUrl>https://nsearchives.nseindia.com/content/circulars/CML74299.pdf</circular:pdfUrl><circular:stock>ATHERENERG</circular:stock><circular:stock>BAJAJHCARE</circular:stock><circular:stock>CREDITACC</circular:stock><circular:stock>ERIS</circular:stock><circular:stock>GHCL</circular:stock><circular:stock>JUSTDIAL</circular:stock><circular:stock>LT</circular:stock><circular:stock>NYKAA</circular:stock><circular:stock>PICCADILY</circular:stock><circular:stock>VIRINCHI</circular:stock><circular:stock>VISHAL</circular:stock><category>listing</category><category>esop</category><category>preferential-allotment</category><category>further-issue</category><category>capital-market</category><category>ATHERENERG</category><category>BAJAJHCARE</category><category>CREDITACC</category><category>ERIS</category><category>GHCL</category><category>JUSTDIAL</category><content:encoded><![CDATA[<h2 id="summary">Summary</h2>
<p>NSE Circular 0806/2026 (Ref: NSE/CML/74299), issued by the Listing Department on May 19, 2026, notifies the admission of further securities to dealings on the NSE Capital Market segment effective May 20, 2026. The circular covers equity shares newly listed for 11 companies, primarily arising from Employee Stock Option Plans (ESOPs) and one preferential allotment.</p>
<h2 id="key-points">Key Points</h2>
<ul>
<li>Effective date for trading of newly listed securities: <strong>May 20, 2026</strong></li>
<li>Securities arise from ESOP allotments (most companies) and one preferential allotment (Bajaj Healthcare)</li>
<li>All new securities are listed as EQ series with Market Lot of 1 and are pari passu with existing shares</li>
<li>Bajaj Healthcare&rsquo;s preferential allotment carries a phased lock-in expiring November 30, 2026 and November 30, 2027</li>
<li>Circular issued under Regulation 3.1.1 and Regulation 2.5.5 of NSE Capital Market Trading Regulations Part A</li>
<li>Signed by Srishti Soni, Manager, NSE</li>
</ul>
<h2 id="regulatory-changes">Regulatory Changes</h2>
<p>No new regulatory changes are introduced. The circular is issued in pursuance of existing Regulations 3.1.1 and 2.5.5 of the NSE (Capital Market) Trading Regulations Part A, which govern admission of further securities to dealings and applicable lot sizes.</p>
<h2 id="compliance-requirements">Compliance Requirements</h2>
<ul>
<li><strong>Members/Brokers</strong>: Must identify securities only by their designated NSE codes for trading purposes; lot sizes as specified in the annexure must be adhered to</li>
<li><strong>Bajaj Healthcare (BAJAJHCARE)</strong>: Lock-in restrictions apply to 2,079,409 preferential shares — 1,169,261 shares locked until <strong>November 30, 2026</strong>, and 910,148 shares locked until <strong>November 30, 2027</strong>; these shares cannot be traded during the lock-in period</li>
<li>No additional compliance action is required for ESOP-allotted shares of other companies</li>
</ul>
<h2 id="important-dates">Important Dates</h2>
<table>
  <thead>
      <tr>
          <th>Event</th>
          <th>Date</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td>Circular issued</td>
          <td>May 19, 2026</td>
      </tr>
      <tr>
          <td>Effective date for new securities trading</td>
          <td>May 20, 2026</td>
      </tr>
      <tr>
          <td>Ather Energy ESOP allotment date</td>
          <td>May 8, 2026</td>
      </tr>
      <tr>
          <td>Bajaj Healthcare Preferential allotment date</td>
          <td>March 18, 2026</td>
      </tr>
      <tr>
          <td>CREDITACCESS GRAMEEN ESOP allotment date</td>
          <td>May 13, 2026</td>
      </tr>
      <tr>
          <td>Eris Lifesciences ESOP allotment date</td>
          <td>May 11, 2026</td>
      </tr>
      <tr>
          <td>GHCL ESOP allotment date</td>
          <td>May 5, 2026</td>
      </tr>
      <tr>
          <td>Bajaj Healthcare lock-in expiry (tranche 1)</td>
          <td>November 30, 2026</td>
      </tr>
      <tr>
          <td>Bajaj Healthcare lock-in expiry (tranche 2)</td>
          <td>November 30, 2027</td>
      </tr>
  </tbody>
</table>
<h2 id="impact-assessment">Impact Assessment</h2>
<p><strong>Market Impact: Low</strong></p>
<p>This is a routine operational circular with minimal market impact:</p>
<ul>
<li><strong>Ather Energy (ATHERENERG)</strong>: 309,372 additional shares (~0.07% dilution for reference) from ESOP; negligible float impact</li>
<li><strong>Bajaj Healthcare (BAJAJHCARE)</strong>: 2,079,409 shares via preferential allotment at Rs. 338/- per share (face value Rs. 5); largest issuance in this circular; majority under lock-in, limiting immediate float increase</li>
<li><strong>CREDITACCESS GRAMEEN (CREDITACC)</strong>: 19,956 ESOP shares; minimal dilution</li>
<li><strong>Eris Lifesciences (ERIS)</strong>: 24,369 ESOP shares; minimal dilution</li>
<li><strong>GHCL</strong>: 196,500 ESOP shares; modest addition</li>
<li><strong>Just Dial, L&amp;T, FSN E-Commerce (Nykaa), Piccadily Agro, Virinchi, Vishal Mega Mart</strong>: Details not fully reproduced in available content; likely similar ESOP-scale additions</li>
</ul>
<p>Investors in these companies should note marginal equity dilution. The Bajaj Healthcare preferential allotment is the only issuance with material lock-in implications for secondary market liquidity.</p>
]]></content:encoded></item></channel></rss>